REGN vs VSTD
Regeneron Pharmaceuticals Inc (REGN) versus Vestand Inc. (VSTD) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Vestand Inc. (VSTD) is a restaurants company listed on NASDAQ.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported VSTD revenue for 2024-12-31 was $12.8M. Net income was -$2.7M. Revenue was up 39.3% from 2023-12-31 to 2024-12-31. VSTD currently screens at market cap $4.5M.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. VSTD currently screens at market cap $4.5M.
Not investment advice. Open the REGN and VSTD stock pages for the full models.
Not investment advice.